期刊
CELLULAR SIGNALLING
卷 26, 期 10, 页码 2234-2239出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2014.07.011
关键词
CD44; CD44v; Alternative splicing; Isoform switch; EMT; CSC
类别
资金
- Ministry of Agriculture [MZE 0002716202]
- Ministry of Education [CZ.1.07/2.3.00/20.0164]
CD44 is a hyaluronan binding cell surface signal transducing receptor that influences motility, cell survival and proliferation as well as the formation of tumor microenvironment CD44 contains two variable regions encoded by variable exons. Alternative splicing, which is often deregulated in cancer, can produce various isoforms of CD44 with properties that may have different tissue specific effects and therefore even diverse effects on cancer progression. This review summarizes and puts together all major regulators of alternative splicing of CD44 in cancer that have been documented so far and that have an experimentally proved effect on CD44 isoform switching. It is important to better understand the mechanisms of alternative splicing of CD44, where all the variability of CD44 originates, to be able to explain the isoform switching and occurrence of variant isoforms of CD44 (CD44v) in cancer. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据